% | $
Quotes you view appear here for quick access.

Exact Sciences Corporation Message Board

  • senior6analyst senior6analyst Jan 20, 2013 10:05 AM Flag

    Misunderstanding of EXAS' advantages over other Tests is Opportunity

    Read my or Earwaxisafuel's posts to understand why EXAS DNA molecular technology is a disruptive, superior technology while EPC's may not. My estimates are that that EXAS's diagnostic kits should sell 10-20 million a year in US and Europe IMHO (explained in earlier posts). The bashers helped me add to my large position last week at around $11.30. If you do your homework and some research, you should have a great opportunity with EXAS. Analysis is better than fanning undeserved fears. Also, look at who owns the stock, the background of management, financial funding, and insider purchases. This should be a great year or buyout for EXAS in my personal opinion.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
11.54+0.45(+4.06%)Jun 24 4:00 PMEDT